Clincosm LogoSign in Get a demo

Hepatitis C

Showing NaN - NaN of 107
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C Trial in Long Island City, New York (diagnostic test, other, drug)

Recruiting
  • Hepatitis C
  • Cepheid POC HCV Viremia (RNA) test
  • +2 more
  • Long Island City, New York
  • +2 more
Dec 20, 2022

Human Immunodeficiency Virus, Hepatitis C, Alcohol Abuse Trial in New York, Saint Petersburg (Computer-based alcohol reduction

Completed
  • Human Immunodeficiency Virus
  • +2 more
  • Computer-based alcohol reduction intervention
  • +2 more
  • New York, New York
  • +1 more
Oct 31, 2022

HCV-TARGET- Hepatitis C Therapeutic Registry and Research

Active, not recruiting
  • Hepatitis C
    • Phoenix, Arizona
    • +59 more
    Oct 5, 2022

    Utilization of MAsS in Patients Undergoing LT for HCC

    Recruiting
    • NAFLD
    • +5 more
      • New York, New York
        Columbia University Irving Medical Center
      Jun 29, 2022

      Renal Failure Chronic, Hepatitis C Trial in United States (glecaprevir/pibrentasvir treatment)

      Completed
      Has Results
      • Renal Failure Chronic
      • Hepatitis C
      • glecaprevir/pibrentasvir treatment
      • Chicago, Illinois
      • +6 more
      Jan 18, 2022

      HIV, Hepatitis C Trial in Puerto Rico, United States (Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT), Dasabuvir (DSV), Ribavirin

      Terminated
      Has Results
      • HIV Infections
      • Hepatitis C
      • Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT)
      • +2 more
      • Birmingham, Alabama
      • +15 more
      Nov 2, 2021

      HIV, Hepatitis C Trial in Puerto Rico, United States (Pegylated-Interferon Alfa 2b (PEG-IFN), Ribavirin (RBV), Boceprevir (BOC))

      Completed
      Has Results
      • HIV Infections
      • Hepatitis C
      • Pegylated-Interferon Alfa 2b (PEG-IFN)
      • +2 more
      • Birmingham, Alabama
      • +42 more
      Nov 2, 2021

      HIV, Hepatitis C Trial in United States (Ribavirin, Interferon alfa-2a, Peginterferon alfa-2a)

      Completed
      • HIV Infections
      • Hepatitis C
      • San Diego, California
      • +23 more
      Oct 28, 2021

      HIV, Hepatitis C Trial in United States (Ribavirin, Aldesleukin, Peginterferon alfa-2b)

      Completed
      • HIV Infections
      • Hepatitis C
      • Los Angeles, California
      • +7 more
      Oct 28, 2021

      An Observational Study of Hepatitis C Virus in Pregnancy

      Completed
      • Hepatitis C
        • Birmingham, Alabama
        • +16 more
        Sep 21, 2021

        Hepatitis C Trial in New York (Mavyret)

        Completed
        Has Results
        • Hepatitis C
        • New York, New York
          New York University School of Medicine
        Sep 1, 2021

        Hepatitis C, People Who Inject Drugs, PWID Trial in New York (Accessible Care, Usual Care)

        Completed
        • Hepatitis C
        • +3 more
        • Accessible Care
        • Usual Care
        • New York, New York
          Lower East Side Harm Reduction Center
        Jul 27, 2021

        Alcohol Use Disorder, HIV/AIDS, Hepatitis C Trial in New York (Intervention: (Clinician's Guide + HealthCall for HIV/HCV))

        Completed
        Has Results
        • Alcohol Use Disorder
        • +3 more
        • Intervention: (Clinician's Guide + HealthCall for HIV/HCV)
        • New York, New York
          NewYork-Presbyterian / Columbia University Medical Center
        Jul 21, 2021

        Direct Acting Antiviral-Post Authorization Safety Study

        Completed
        • Hepatitis C
        • Hepatocellular Carcinoma
          • Phoenix, Arizona
          • +61 more
          Jul 1, 2021

          Hepatitis C Trial in Worldwide (telaprevir, ribavirin, peginterferon alfa-2a)

          Completed
          Has Results
          • Hepatitis C
          • Birmingham, Alabama
          • +81 more
          Mar 3, 2021

          Eliminating Hepatitis C Virus

          Completed
          • Hepatitis C
          • +2 more
            • New York, New York
              Icahn School of Medicine at Mount Sinai
            Mar 23, 2021

            Hepatitis C, Transplantation Disease Transmission Trial in United States (Sofosbuvir/Velpatasvir,

            Completed
            Has Results
            • Hepatitis C
            • Transplantation Disease Transmission
            • San Francisco, California
            • +5 more
            Feb 10, 2021

            HIV, Hepatitis C, Cirrhosis Trial in United States (Harvoni)

            Completed
            Has Results
            • HIV
            • +2 more
            • San Francisco, California
            • +7 more
            Jan 12, 2021

            Hepatitis C, Cryoglobulinemia Trial in New York (Harvoni, Epclusa)

            Completed
            Has Results
            • Hepatitis C
            • Cryoglobulinemia
            • New York, New York
              Icahn School of Medicine at Mount Sinai
            Nov 23, 2020

            Liver Diseases, Alcoholic, Alcoholism, HIV Trial in United States (Integrated Stepped Care (ISC), Treatment as Usual)

            Completed
            • Liver Diseases, Alcoholic
            • +3 more
            • Integrated Stepped Care (ISC)
            • Treatment as Usual
            • Washington, District of Columbia
            • +4 more
            Nov 5, 2020

            Hepatitis C, HIV, AIDS Trial in United States (Control Group, Care Facilitation Group)

            Completed
            • Hepatitis C
            • +3 more
            • Control Group
            • Care Facilitation Group
            • Birmingham, Alabama
            • +10 more
            Jul 21, 2020

            Hepatitis C, Medication Adherence Trial in New York (HepCure ToolKit, AdhereTech Active Features, AdhereTech Passive Monitoring)

            Completed
            • Hepatitis C
            • Medication Adherence
            • HepCure ToolKit
            • +2 more
            • New York, New York
              Icahn School of Medicine at Mount Sinai
            Mar 19, 2020

            HIV/AIDS, Hepatitis C, Substance Use Disorders Trial in New York (Information Control, HIV and HCV Testing Practice Coaching

            Unknown status
            • HIV/AIDS
            • +3 more
            • Information Control
            • +2 more
            • New York, New York
              Columbia University Medical Center
            Mar 3, 2020

            Hepatitis C, HCV Trial in United States (Glecaprevir/Pibrentasvir (G/P) 300mg/120mg, Ribavirin 200Mg Tablet)

            Completed
            Has Results
            • Hepatitis C
            • HCV
            • Glecaprevir/Pibrentasvir (G/P) 300mg/120mg
            • Ribavirin 200Mg Tablet
            • Palo Alto, California
            • +30 more
            Feb 17, 2020

            Hepatitis C Trial in New York (Zoster vaccine live)

            Terminated
            Has Results
            • Hepatitis C
            • Zoster vaccine live
            • New York, New York
              Rockefeller University Hospital
            Dec 16, 2019